Sharechat Logo

Metlifecare Confirms ASX Listing

Friday 18th October 2013

Text too small?

Metlifecare, one of New Zealand’s leading retirement village and aged care providers, has been advised by the Australian Securities Exchange that it has been admitted to the Official List of the ASX.

Metlifecare shares will commence trading on the ASX, under the code MEQ at 1.00pm (A.E.S.T.) on 21 October 2013. The ticker code for the NZX will remain as MET. Metlifecare will be a member of the healthcare index. Metlifecare has prepared the attached Prospectus as part of the ASX listing process. Metlifecare is not undertaking any capital raising and has no current plans to do so.

Chairman of Metlifecare, Mr Peter Brown, said: “This secondary listing will provide Metlifecare with additional access to investors and the Australian equity markets. While we already have a number of Australian institutional investors on our share register, there has been increased interest from other investors, some of whom are restricted in their ability to invest into non-ASX listed companies. This will provide them with an opportunity to participate in Metlifecare’s growth and value proposition. We have no plans to expand operationally into Australia and are firmly focused on the significant opportunity in the New Zealand market, particularly in our targeted geographical area in the upper North Island and achieving our growth targets.”

Computershare will continue as Metlifecare’s share registrar in New Zealand and now Australia. Shareholders will be able to trade their shares on either the NZX or the ASX, dependent on which share register their shares are registered with. Currently all MET shareholders are registered in New Zealand. They will have the option of transferring their shares onto the Australian register should they prefer.




  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

December 27th Morning Report
FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors